Entering text into the input field will update the search result below

Mass Spectrometry Market Worth USD 5.6 Billion: Competitive Strategy, Benchmarking And Demand Trend Analysis

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Seeking Alpha Analyst Since 2014

#Healthcare Consultant focusing on #TeleHealth #TeleMedicine #PatientPortals #CVIS #HCIT #MedicalRobots #Vaccines #MedicalDevices #WirelessHealth #Biotechnology


  • In 2020, Shimadzu expanded its operation by establishing its branch office in Copenhagen, Denmark. This expansion focuses on providing its full range of analytical instrumentation solutions in the region.
  • In 2019, Agilent Technologies partnered with MOBILion Systems for ion mobility separation technology on its Q-TOF mass spectrometers.

The mass spectrometry market size is expected to grow from an estimated USD 4.1 billion in 2020 to USD 5.6 billion by 2025, at a CAGR of 6.5% during the forecast period. Increasing spending on pharmaceutical R&D across the globe, government regulations on drug safety, growing focus on the quality of food products, increase in crude and shale gas production, and growing government initiatives for pollution control and environmental testing are high growth prospects for the mass spectrometry market during the forecast period.

Mass Spectrometry Market (MarketsandMarkets)

Competitive Landscape:

The competitive landscape includes the analysis of the key growth strategies adopted by major players to expand their global presence and increase their market shares in the radiotherapy market. The key growth strategies adopted by the top players in the market include product launches and approvals, agreements, expansions, and acquisitions. Product approvals and launches were the most widely adopted growth strategies by market players in the last three years to garner a larger share of the market.

The pharmaceutical industry end-user segment is expected to grow at the highest CAGR

Pharmaceutical industries are among the key end-users of mass spectrometers. the Tvailability of government and corporate funding for pharmaceutical research, growth of the pharmaceutical industry, and the presence of stringent regulatory guidelines for drug development and safety are some of the key factors driving the growth of this segment during the forecast period.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=437

Key Players:

  • Thermo Fisher Scientific (US),
  • SCIEX (US)
  • Agilent Technologies (US),
  • Waters Corporation (US),
  • PerkinElmer (US),
  • Shimadzu Corporation (Japan),
  • Bruker (US),
  • Analytik Jena (Germany),
  • JEOL (Japan),
  • Rigaku (Japan),
  • DANI Instruments (OTCPK:ITALY),
  • LECO (US),
  • Hiden Analytical (UK)

Get more crucial market insights:https://www.prnewswire.com/news-releases/mass-spectrometry-market-worth-5-6-billion-by-2025--exclusive-report-by-marketsandmarkets-301218756.html

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.